Search hospitals > Michigan > Southfield
Ascension Providence Hospitals - Southfield
Claim this profileSouthfield, Michigan 48075
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Multiple Myeloma
235 reported clinical trials
10 medical researchers
Summary
Ascension Providence Hospitals - Southfield is a medical facility located in Southfield, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Multiple Myeloma and other specialties. Ascension Providence Hospitals - Southfield is involved with conducting 235 clinical trials across 313 conditions. There are 10 research doctors associated with this hospital, such as Adam M. Forman, Susan E. Lyons, Cynthia M. Vakhariya, and Howard R. Terebelo.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Adam M. FormanAscension Providence Hospitals - Southfield2 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
25 reported clinical trials
46 drugs studied
Susan E. LyonsAscension Providence Hospitals - Southfield6 years of reported clinical research
Studies Pancreatic Cancer
Studies Colon Cancer
20 reported clinical trials
39 drugs studied
Cynthia M. VakhariyaAscension Providence Hospitals - Southfield10 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
13 reported clinical trials
27 drugs studied
Howard R. TerebeloAscension Providence Hospitals - Southfield2 years of reported clinical research
Studies Multiple Myeloma
Studies Lymphoma
6 reported clinical trials
13 drugs studied
Clinical Trials running at Ascension Providence Hospitals - Southfield
Lung Cancer
Multiple Myeloma
Breast Cancer
Esophageal cancer
Heart Failure
Non-Small Cell Lung Cancer
Pancreatic Carcinoma
Breast cancer
Gastric cancer
Atrial Fibrillation
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 242 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ascension Providence Hospitals - Southfield?
Ascension Providence Hospitals - Southfield is a medical facility located in Southfield, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Multiple Myeloma and other specialties. Ascension Providence Hospitals - Southfield is involved with conducting 235 clinical trials across 313 conditions. There are 10 research doctors associated with this hospital, such as Adam M. Forman, Susan E. Lyons, Cynthia M. Vakhariya, and Howard R. Terebelo.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.